Back to Search
Start Over
Cholesterol Risk Management: A Systematic Examination of the Gap from Evidence to Practice
- Source :
- Pharmacotherapy. 21:807-817
- Publication Year :
- 2001
- Publisher :
- Wiley, 2001.
-
Abstract
- Hypercholesterolemia is a major risk factor for coronary heart disease, and data indicate that aggressive cholesterol reduction decreases mortality and morbidity associated with this disease. Many patients with hypercholesterolemia, however, are not screened, prescribed appropriate lipid-lowering therapy, or treated to target cholesterol levels. Practice patterns are particularly inadequate for those patients at highest risk for having a cardiac event. We performed a literature search to identify studies of practice patterns in the management of patients with hypercholesterolemia with regard to screening, implementing lipid-lowering therapy, and treating to lipid goals. The findings highlight the potential for substantial opportunities to improve patient outcomes. Future studies should evaluate reasons for suboptimal cholesterol management as well as provide steps to improve management.
- Subjects :
- Cardiovascular event
medicine.medical_specialty
Future studies
Hypercholesterolemia
Disease
chemistry.chemical_compound
Risk Factors
medicine
Animals
Humans
Pharmacology (medical)
Risk factor
Intensive care medicine
Risk management
Cholesterol management
Clinical Trials as Topic
Evidence-Based Medicine
Cholesterol
business.industry
Anticholesteremic Agents
Coronary heart disease
Surgery
chemistry
Practice Guidelines as Topic
lipids (amino acids, peptides, and proteins)
business
Subjects
Details
- ISSN :
- 02770008
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Pharmacotherapy
- Accession number :
- edsair.doi.dedup.....b2fc1e40de38b039c86d8f64b3d7fd27